|Articles|April 4, 2017
Karyopharm and Medidata Expand Partnership
Medidata and pharma company Karyopharm Therapeutics announce an expanded partnership.
Advertisement
Medidata and pharma company Karyopharm Therapeutics announce an expanded partnership to bring machine-learning technology and targeted risk-based monitoring techniques to oncology clinical trials.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: AstraZeneca Expands Immunotherapy Reach as Thermo Fisher’s $8.8B Deal Signals New Phase for Digital Trials
2
Engineered Bispecific Antibodies: Regulatory, Ethical, and Best Practice Guidelines
3
MATTERHORN Trial Findings Signal Paradigm Shift in Early Gastric Cancer Care
4
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
